ArticleBreast cancer research and treatment2023

HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.

Harriet T Rothschild et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.